Chimeric Animal Immune Response Management System

The original patent disclosed a method for treating and preventing immune response and inflammation in chimeric animals. However, the patent had limitations in terms of real-time monitoring, personalized treatment, and secure data management. The present invention addresses these limitations by synergistically combining distinct technologies to create a more powerful system.

The new claims introduce the integration of AI, IoT, blockchain, and genomics analysis, which is not obvious from the original patent. The inventive step lies in the synergistic combination of these technologies to create a more powerful system that addresses the limitations of the original patent.

Alternative embodiments of the invention could include the use of different machine learning algorithms, integration with other IoT devices, or the incorporation of additional genomic analysis tools. Variations of the invention could also include the application of the system to other animal models or human subjects.

The integrated system has significant commercial potential in the fields of veterinary medicine, biotechnology, and pharmaceuticals. The system could be marketed to research institutions, veterinary hospitals, and pharmaceutical companies, providing a comprehensive solution for immune response and inflammation management in chimeric animals.